IL6 and breast cancer: The levels of interleukin IL-6 and IL-6 receptors in women after breast cancer treatment have also been investigated, and these studies revealed that the IL-6 signaling pathway may be an important biological mechanism associated with the persistence of the painful symptoms of CIPN, which may have potential implications for the management of CIPN symptoms [112].